Oncology & Cancer

Medicare confirms payment for prostate cancer drug

(AP) -- Medicare officials confirmed Thursday that the program will cover the $93,000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease ...

Medications

US pharmacy giant buys rival for $29.1 billion

Pharmacy benefits manager Express Scripts said Thursday it had reached a deal to buy its competitor Medco Health Systems for $29.1 billion, ahead of looming changes in the US healthcare system.

HIV & AIDS

Two-thirds of Myanmar HIV patients untreated: MSF

International funding cuts threaten to deepen an HIV crisis in Myanmar, where tens of thousands of people are denied lifesaving treatment, an aid agency said Wednesday.

Arthritis & Rheumatism

Making musculoskeletal health a global priority

An international research team has found that despite being the world's leading cause of pain, disability and healthcare expenditure, the prevention and management of musculoskeletal health, including conditions such as low ...

Other

Study evaluates industry payments to orthopedic surgeons

An analysis of financial payments made by orthopedic device manufacturers to orthopedic surgeons shows that the patterns of payments from 2007 to 2010 appear to be complex with a reduction in the total number of payments ...

Medications

Research suggests off-label prescribing of medications is common

A study evaluating off-label prescribing of medications in a primary care network in Canada suggests the practice is common, although it varies by medication, patient and physician characteristics, according to a report published ...

Diseases, Conditions, Syndromes

Myanmar must act fast to curb drug resistant TB, experts say

Health officials called Thursday for urgent action to tackle "alarming" rates of drug-resistant tuberculosis in Myanmar where nearly 9,000 people catch the strain of the infectious disease each year.

page 1 from 6